Diazepam NDC 0172-3925

NDC codes

FDA NDC Directory

Product NDC (as listed)0172-3925Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00172-3925Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0172-3925-60	00172392560	100 TABLET in 1 BOTTLE (0172-3925-60)Marketed from Dec 10, 1986
0172-3925-70	00172392570	500 TABLET in 1 BOTTLE (0172-3925-70)Marketed from Oct 18, 2000

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diazepam
Generic name (nonproprietary): diazepam
Active ingredients: Diazepam — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071307
Marketing start: Dec 10, 1986
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 0172-3925_db225e5f-9265-4460-ab58-3305246c6258SPL ID db225e5f-9265-4460-ab58-3305246c6258SPL set ID 48aa32cb-047a-414a-822e-82a5f26d8817RxCUI 197589, 197590, 197591UNII Q3JTX2Q7TUUPC 0301723926609, 0301723927606, 0301723925602
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400172392560 followed by a unit qualifier and the quantity

Package 00172-3925-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS Diazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, diazepam tablets may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), at…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071307

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071307
Product	Strength	Form · route	Labeler	Product NDC
Diazepam	Diazepam 2 mg/1	TabletOral	Bryant Ranch Prepack	63629-2948
Diazepam	Diazepam 2 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-840
Diazepam	Diazepam 2 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	43353-825
Diazepam	Diazepam 2 mg/1	TabletOral	Asclemed USA, Inc.	76420-783
Diazepam	Diazepam 2 mg/1	TabletOral	Clinical Solutions Wholesale, LLC	58118-3925
Diazepam	Diazepam 2 mg/1	TabletOral	A-S Medication Solutions	50090-0195